Klasse P J, Rosenkilde M M, Signoret N, Pelchen-Matthews A, Schwartz T W, Marsh M
MRC Laboratory for Molecular Cell Biology and Department of Biochemistry and Molecular Biology, University College London, London WC1E 6BT, United Kingdom.
J Virol. 1999 Sep;73(9):7453-66. doi: 10.1128/JVI.73.9.7453-7466.1999.
Most human immunodeficiency virus (HIV) strains require both CD4 and a chemokine receptor for entry into a host cell. In order to analyze how the HIV-1 envelope glycoprotein interacts with these cellular molecules, we constructed single-molecule hybrids of CD4 and chemokine receptors and expressed these constructs in the mink cell line Mv-1-lu. The two N-terminal (2D) or all four (4D) extracellular domains of CD4 were linked to the N terminus of the chemokine receptor CXCR4. The CD4(2D)CXCR4 hybrid mediated infection by HIV-1(LAI) to nearly the same extent as the wild-type molecules, whereas CD4(4D)CXCR4 was less efficient. Recombinant SU(LAI) protein competed more efficiently with the CXCR4-specific monoclonal antibody 12G5 for binding to CD4(2D)CXCR4 than for binding to CD4(4D)CXCR4. Stromal cell-derived factor 1 (SDF-1) blocked HIV-1(LAI) infection of cells expressing CD4(2D)CXCR4 less efficiently than for cells expressing wild-type CXCR4 and CD4, whereas down-modulation of CXCR4 by SDF-1 was similar for hybrids and wild-type CXCR4. In contrast, the bicyclam AMD3100, a nonpeptide CXCR4 ligand that did not down-modulate the hybrids, blocked hybrid-mediated infection at least as potently as for wild-type CXCR4. Thus SDF-1, but not the smaller molecule AMD3100, may interfere at multiple points with the binding of the surface unit (SU)-CD4 complex to CXCR4, a mechanism that the covalent linkage of CD4 to CXCR4 impedes. Although the CD4-CXCR4 hybrids yielded enhanced SU interactions with the chemokine receptor moiety, this did not overcome the specific coreceptor requirement of different HIV-1 strains: the X4 virus HIV-1(LAI) and the X4R5 virus HIV-1(89. 6), unlike the R5 strain HIV-1(SF162), infected Mv-1-lu cells expressing the CD4(2D)CXCR4 hybrid, but none could use hybrids of CD4 and the chemokine receptor CCR2b, CCR5, or CXCR2. Thus single-molecule hybrid constructs that mimic receptor-coreceptor complexes can be used to dissect coreceptor function and its inhibition.
大多数人类免疫缺陷病毒(HIV)毒株进入宿主细胞需要CD4和一种趋化因子受体。为了分析HIV-1包膜糖蛋白如何与这些细胞分子相互作用,我们构建了CD4与趋化因子受体的单分子杂交体,并在貂细胞系Mv-1-lu中表达这些构建体。CD4的两个N端(2D)或所有四个(4D)细胞外结构域与趋化因子受体CXCR4的N端相连。CD4(2D)CXCR4杂交体介导HIV-1(LAI)感染的效率与野生型分子几乎相同,而CD4(4D)CXCR4的效率较低。重组SU(LAI)蛋白与CXCR4特异性单克隆抗体12G5竞争结合CD4(2D)CXCR4比结合CD4(4D)CXCR4更有效。基质细胞衍生因子1(SDF-1)阻断表达CD4(2D)CXCR4的细胞被HIV-1(LAI)感染的效率低于表达野生型CXCR4和CD4的细胞,而SDF-1对CXCR4的下调在杂交体和野生型CXCR4中相似。相比之下,双环胺AMD3100是一种不会下调杂交体的非肽CXCR4配体,它阻断杂交体介导的感染的效力至少与野生型CXCR4相同。因此,SDF-1而非较小的分子AMD3100可能在多个点干扰表面单位(SU)-CD4复合物与CXCR4的结合,这种机制是CD4与CXCR4的共价连接所阻碍的。尽管CD4-CXCR4杂交体增强了SU与趋化因子受体部分的相互作用,但这并未克服不同HIV-1毒株对特异性共受体的需求:X4病毒HIV-1(LAI)和X4R5病毒HIV-1(89.6),与R5毒株HIV-1(SF1)不同,感染表达CD4(2D)CXCR4杂交体的Mv-1-lu细胞,但没有一种能够利用CD4与趋化因子受体CCR2b、CCR5或CXCR2的杂交体。因此,模拟受体-共受体复合物的单分子杂交构建体可用于剖析共受体功能及其抑制作用。